Navigation Links
Wyeth's Torisel and Roche/Genentech's Avastin Will Challenge Pfizer's Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
Date:8/19/2007

Increased Survival Rates and Decreased Disease Progression Rates Are the

Advantages, According to a New Report from Decision Resources

WALTHAM, Mass., Aug. 7 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Wyeth's Torisel and Roche/Genentech's Avastin will challenge Pfizer's Sutent as the clinical gold standard for the treatment of metastatic renal cell carcinoma. According to the new report entitled Two Hot New Drugs Battle for Top Position: A Renal Cell Carcinoma Study, both Torisel and Avastin offer increased overall survival rates as well as decreased disease progression times.

"Metastatic renal cell carcinoma is an end-stage disease in which the primary goal of treatment is to prolong survival," said Mohamed Muhsin, analyst at Decision Resources. "Phase III clinical trials have shown Torisel to increase the median overall survival rates of patients by 49 percent. High rates of partial response and stable disease, extended median time to progression, and overall survival rates for patients on Torisel are promising. Phase II trials for Avastin have shown that 61% of patients had stable disease. The median progression-free survival rate was eleven months, and the one-year progression-free survival rates for patients with objective response, minor response, and stable disease were 80%, 57% and 27%, respectively."

About Two Hot New Drugs Battle for Top Position: A Renal Cell Carcinoma Study

Two Hot New Drugs Battle for Top Position: A Renal Cell Carcinoma Study covers the current and future state of the metastatic renal cell carcinoma drug market. The report includes the following:

-- More than 3,000 physician responses that define drug attributes that

drive prescription now and in the future.

* Clinical end point tradeoffs that are most influential to

physicians.

* Areas o
'/>"/>

SOURCE Decision Resources, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
2. FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer
3. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
4. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
5. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
6. Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis
7. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
8. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
9. Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
10. LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization
11. Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan Canada ... its Board of Directors, enhancing executive oversight and ... a leading licensed producer of medicinal cannabis in ... 13 years, experience in producing and supplying government-regulated ... Canada. As previously announced in ...
(Date:8/21/2014)... (NASDAQ: CYBX ) today announced results for the ... 1   Operating results for the first quarter ... 2014, and other achievements, include: , Worldwide net product ... Strong international net sales of $13.2 million, an increase of ... product sales reached a new high of $58.8 million, an ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... SANTA MARIA, Calif., Feb. 14, 2011 Hardy Diagnostics, ... the release of HardyCHROM™ SS, a highly selective chromogenic ... for the isolation and differentiation of Salmonella ... two pathogens can be easily distinguished from non-pathogenic enteric ...
... MedQuist Holdings Inc. (Nasdaq: MEDH ), formerly ... documentation solutions for the U.S. healthcare system, today announced ... shares of its common stock.  The shares began trading ... under the ticker symbol MEDH. In ...
Cached Medicine Technology:The Only Chromogenic Medium That Detects Both Salmonella and Shigella! 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 3
(Date:8/21/2014)... Line: Patients with advanced laryngeal cancer appear to ... surgery than nonsurgical chemoradiation. , Author: Uchechukwu C. ... Medicine at Mount Sinai, New York, and colleagues. ... laryngeal cancer are diagnosed each year and squamous ... these tumors. Prior to 1991, total surgical removal ...
(Date:8/21/2014)... Improv performers from Fun House Theatre and ... Silverado Turtle Creek memory care community in Dallas. The ... from ages 10 to 16, delivers a groundbreaking and ... The troupe's philosophy is that improv is based on ... touch audiences regardless of their circumstance — including bringing ...
(Date:8/21/2014)... have pinpointed the environmental source of fungal infections that ... decades. It literally grows on trees. , The discovery ... girl, who spent the summer gathering soil and tree ... infections of the fungus named Cryptococcus gattii ... encompasses a number of species including C. gattii ...
(Date:8/21/2014)... California (PRWEB) August 21, 2014 The ... initial plans for entertainment and programming for its inaugural ... On Sunday, October 12, 2014, from 11 a.m. to ... closed to all cars and the downtown will be ... activities, curated by Community Arts Resources (CARS), for all ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Not only is eating ... save them hundreds of health-care dollars a year, a new ... professor of public health sciences at Wake Forest Baptist Medical ... and obese type 2 diabetes patients. Participants ... assigned to either an intensive "lifestyle change program" focused on ...
Breaking Medicine News(10 mins):Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2
... PURCHASE, N.Y., March 30 Nutrition 21 is ... and Chief Executive Officer, has been elected to ... Products Association (CHPA). CHPA is a 128-year ... over-the-counter medicines and nutritional supplement products. Members ...
... Year According to the Better Sleep CouncilDALLAS, March 30 ... is usually one of the first things people scrimp on ... turbulent economy, nearly 30 percent of Americans lose sleep ... a 2009 Sleep in America poll by the National Sleep ...
... A health insurance protocol intended to ... barriers that lead people to receive less of needed ... result, patients ultimately require more -- and more costly ... plan members to try a first-line medication before they ...
... of chronic illnesses in Europe and the consequent ... has amplified the need for equipment that measure ... This rise in the number of people requiring ... and transducers.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )New analysis from ...
... Q-Stress and Q-Tel cardiac rehab to healthcare information ... CSCX ), a global leader in ... today added DICOM connectivity to its Quinton Q-Stress ... rehabilitation system. "With DICOM and HL7 technologies, Cardiac ...
... Kachmann teaches how the connection between mind, body ... Ind., March 30 For residents of Ft. ... Kachmann Mind Body Institute ( www.kachmannmindbody.com ) noted ... health and the arts. Now, having retained award-winning ...
Cached Medicine News:Health News:Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association Board 2Health News:Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association Board 3Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 2Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 3Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 2Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 4Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 2Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 3Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 4Health News:Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record 2
Nidek offers 3-Dx Digital stereo camera to provide a complete and comprehensive digital imaging platform....
Measurement of progressive multi-focal lenses is fast and easy with the CLM-3000 auto-lensmeter. The data is represented in a simple to understand bar graphic display....
Auto Lensmeter LM-970...
Autolensmeter with black/white monitor and no internal printer....
Medicine Products: